Iomeron

Iomeprol, the active ingredient in Iomeron, is a non‑ionic iodinated contrast media presented as a sterile solution for injection for intra‑arterial, intra‑articular and intrathecal administration. It enhances X‑ray attenuation of extracellular fluids, allowing clear visualization of vascular, joint and spinal canal structures during diagnostic imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, diagnostic imaging centres, clinics and procurement teams worldwide under controlled conditions. Our distribution network ensures timely availability and compliance with local regulatory requirements.

Iomeron (iomeprol) is an iodinated contrast agent employed in radiographic procedures that require enhanced visualization of vascular and fluid‑filled spaces.

- Angiography: provides high‑contrast images of blood vessels to aid in the diagnosis of vascular diseases and guide interventional procedures. - Arthrography: improves delineation of joint spaces, facilitating assessment of cartilage, ligaments and intra‑articular pathology. - Myelography: enhances imaging of the spinal canal and nerve roots, supporting evaluation of spinal stenosis, disc herniation and tumors. - Other diagnostic imaging procedures requiring intra‑arterial, intra‑articular or intrathecal contrast: delivers reliable contrast enhancement for a variety of specialized studies.

Iomeron may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Warm sensation at injection site - Nausea or vomiting - Metallic taste in the mouth - Transient headache or flushing

Serious or Rare Side Effects: - Severe allergic reaction including anaphylaxis - Acute renal impairment or contrast‑induced nephropathy - Significant hypotension or cardiovascular collapse - Pulmonary edema or respiratory distress

Prior to administering Iomeron, clinicians should observe several precautionary measures to minimize risk. - Assess renal function: evaluate eGFR or serum creatinine before use. - Review allergy history: identify previous reactions to iodinated contrast agents. - Use pre‑medication: consider antihistamines or steroids for patients with known sensitivity. - Ensure adequate hydration: encourage fluid intake before and after the procedure. - Store at ambient temperature: keep the solution in its original container, protect from light and moisture.

Iomeron can interact with certain medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Metformin (high dose): concurrent use may increase risk of lactic acidosis in patients with impaired renal function. - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): combined exposure can exacerbate renal injury. - Other iodine‑containing radiopharmaceuticals: cumulative iodine load may affect thyroid function.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: iodine load may alter hormone levels, necessitating monitoring. - Diuretics: may influence fluid balance and affect contrast distribution. - ACE inhibitors or ARBs: potential for enhanced renal effects, especially in patients with pre‑existing kidney disease.